![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: WDR5 |
Gene summary for WDR5 |
![]() |
Gene information | Species | Human | Gene symbol | WDR5 | Gene ID | 11091 |
Gene name | WD repeat domain 5 | |
Gene Alias | BIG-3 | |
Cytomap | 9q34.2 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | P61964 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11091 | WDR5 | HTA11_347_2000001011 | Human | Colorectum | AD | 7.89e-03 | 1.86e-01 | -0.1954 |
11091 | WDR5 | HTA11_1391_2000001011 | Human | Colorectum | AD | 8.06e-05 | 3.75e-01 | -0.059 |
11091 | WDR5 | HTA11_7862_2000001011 | Human | Colorectum | AD | 5.91e-03 | 3.19e-01 | -0.0179 |
11091 | WDR5 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.09e-06 | 3.44e-01 | 0.096 |
11091 | WDR5 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.22e-03 | 2.23e-01 | 0.0674 |
11091 | WDR5 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.11e-04 | 3.35e-01 | 0.294 |
11091 | WDR5 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 3.51e-02 | 7.47e-01 | 0.3487 |
11091 | WDR5 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 5.05e-09 | 5.25e-01 | 0.281 |
11091 | WDR5 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.29e-18 | 7.05e-01 | 0.3859 |
11091 | WDR5 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.89e-07 | 3.73e-01 | 0.3005 |
11091 | WDR5 | A015-C-203 | Human | Colorectum | FAP | 3.29e-02 | -7.49e-02 | -0.1294 |
11091 | WDR5 | A002-C-116 | Human | Colorectum | FAP | 2.00e-05 | -1.43e-01 | -0.0452 |
11091 | WDR5 | LZE4T | Human | Esophagus | ESCC | 1.35e-02 | 6.12e-02 | 0.0811 |
11091 | WDR5 | LZE20T | Human | Esophagus | ESCC | 2.89e-04 | 1.70e-01 | 0.0662 |
11091 | WDR5 | LZE24T | Human | Esophagus | ESCC | 1.17e-10 | 3.24e-01 | 0.0596 |
11091 | WDR5 | LZE21T | Human | Esophagus | ESCC | 2.34e-03 | 3.59e-01 | 0.0655 |
11091 | WDR5 | P1T-E | Human | Esophagus | ESCC | 5.88e-04 | 3.33e-01 | 0.0875 |
11091 | WDR5 | P2T-E | Human | Esophagus | ESCC | 1.51e-50 | 9.32e-01 | 0.1177 |
11091 | WDR5 | P4T-E | Human | Esophagus | ESCC | 3.19e-28 | 6.97e-01 | 0.1323 |
11091 | WDR5 | P5T-E | Human | Esophagus | ESCC | 1.57e-30 | 6.36e-01 | 0.1327 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003812720 | Thyroid | PTC | ERBB signaling pathway | 66/5968 | 121/18723 | 1.97e-07 | 3.54e-06 | 66 |
GO:0009267112 | Thyroid | PTC | cellular response to starvation | 80/5968 | 156/18723 | 3.52e-07 | 5.90e-06 | 80 |
GO:0031667113 | Thyroid | PTC | response to nutrient levels | 201/5968 | 474/18723 | 7.00e-07 | 1.10e-05 | 201 |
GO:000717320 | Thyroid | PTC | epidermal growth factor receptor signaling pathway | 59/5968 | 108/18723 | 8.00e-07 | 1.23e-05 | 59 |
GO:0006898110 | Thyroid | PTC | receptor-mediated endocytosis | 112/5968 | 244/18723 | 2.87e-06 | 3.74e-05 | 112 |
GO:004825918 | Thyroid | PTC | regulation of receptor-mediated endocytosis | 55/5968 | 110/18723 | 5.64e-05 | 4.99e-04 | 55 |
GO:004311219 | Thyroid | PTC | receptor metabolic process | 77/5968 | 166/18723 | 6.21e-05 | 5.47e-04 | 77 |
GO:190118410 | Thyroid | PTC | regulation of ERBB signaling pathway | 41/5968 | 79/18723 | 1.70e-04 | 1.31e-03 | 41 |
GO:004205810 | Thyroid | PTC | regulation of epidermal growth factor receptor signaling pathway | 38/5968 | 73/18723 | 2.69e-04 | 1.91e-03 | 38 |
GO:19909286 | Thyroid | PTC | response to amino acid starvation | 27/5968 | 49/18723 | 6.38e-04 | 4.02e-03 | 27 |
GO:00319295 | Thyroid | PTC | TOR signaling | 57/5968 | 126/18723 | 1.12e-03 | 6.56e-03 | 57 |
GO:00341986 | Thyroid | PTC | cellular response to amino acid starvation | 24/5968 | 46/18723 | 3.34e-03 | 1.63e-02 | 24 |
GO:00510518 | Thyroid | PTC | negative regulation of transport | 176/5968 | 470/18723 | 5.44e-03 | 2.49e-02 | 176 |
GO:00320083 | Thyroid | PTC | positive regulation of TOR signaling | 23/5968 | 47/18723 | 1.09e-02 | 4.35e-02 | 23 |
GO:002261334 | Thyroid | ATC | ribonucleoprotein complex biogenesis | 292/6293 | 463/18723 | 3.05e-39 | 9.63e-36 | 292 |
GO:004225434 | Thyroid | ATC | ribosome biogenesis | 203/6293 | 299/18723 | 3.63e-34 | 4.59e-31 | 203 |
GO:000636432 | Thyroid | ATC | rRNA processing | 157/6293 | 225/18723 | 9.02e-29 | 5.70e-26 | 157 |
GO:001607232 | Thyroid | ATC | rRNA metabolic process | 161/6293 | 236/18723 | 1.02e-27 | 5.89e-25 | 161 |
GO:003447021 | Thyroid | ATC | ncRNA processing | 216/6293 | 395/18723 | 3.14e-18 | 3.98e-16 | 216 |
GO:003466021 | Thyroid | ATC | ncRNA metabolic process | 240/6293 | 485/18723 | 2.03e-13 | 9.91e-12 | 240 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
WDR5 | SNV | Missense_Mutation | rs746477625 | c.949N>A | p.Ala317Thr | p.A317T | P61964 | protein_coding | deleterious(0.03) | possibly_damaging(0.554) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
WDR5 | SNV | Missense_Mutation | novel | c.906N>G | p.Asp302Glu | p.D302E | P61964 | protein_coding | deleterious(0.04) | benign(0.058) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
WDR5 | SNV | Missense_Mutation | novel | c.221N>T | p.Ala74Val | p.A74V | P61964 | protein_coding | tolerated(0.25) | benign(0.005) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
WDR5 | SNV | Missense_Mutation | c.689N>C | p.Leu230Pro | p.L230P | P61964 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
WDR5 | SNV | Missense_Mutation | c.874N>C | p.Glu292Gln | p.E292Q | P61964 | protein_coding | tolerated(0.11) | benign(0.267) | TCGA-F4-6809-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
WDR5 | deletion | Frame_Shift_Del | c.642delN | p.Val217CysfsTer4 | p.V217Cfs*4 | P61964 | protein_coding | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |||
WDR5 | insertion | Frame_Shift_Ins | rs780890680 | c.648dupC | p.Val217ArgfsTer42 | p.V217Rfs*42 | P61964 | protein_coding | TCGA-AA-3713-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | 5-fluorouracil | PR | ||
WDR5 | deletion | Frame_Shift_Del | c.642delN | p.Val217CysfsTer4 | p.V217Cfs*4 | P61964 | protein_coding | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
WDR5 | deletion | Frame_Shift_Del | c.648delC | p.Val217CysfsTer4 | p.V217Cfs*4 | P61964 | protein_coding | TCGA-AU-6004-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
WDR5 | deletion | Frame_Shift_Del | c.642delN | p.Val217CysfsTer4 | p.V217Cfs*4 | P61964 | protein_coding | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
11091 | WDR5 | DRUGGABLE GENOME, TUMOR SUPPRESSOR | antagonist | 249565911 |
Page: 1 |